MOTEXAFIN GADOLINIUM COMBINED WITH PROMPT WHOLE BRAIN RADIOTHERAPY PROLONGS TIME TO NEUROLOGIC PROGRESSION IN NON-SMALL-CELL LUNG CANCER PATIENTS WITH BRAIN METASTASES: RESULTS OF A PHASE III TRIAL Article

Mehta, Minesh P, Shapiro, William R, Phan, See C et al. (2009). MOTEXAFIN GADOLINIUM COMBINED WITH PROMPT WHOLE BRAIN RADIOTHERAPY PROLONGS TIME TO NEUROLOGIC PROGRESSION IN NON-SMALL-CELL LUNG CANCER PATIENTS WITH BRAIN METASTASES: RESULTS OF A PHASE III TRIAL . INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 73(4), 1069-1076. 10.1016/j.ijrobp.2008.05.068

Industry Collaboration International Collaboration

cited authors

  • Mehta, Minesh P; Shapiro, William R; Phan, See C; Gervais, Radj; Carrie, Christian; Chabot, Pierre; Patchell, Roy A; Glantz, Michael J; Recht, Lawrence; Langer, Corey; Sur, Ranjan K; Roa, Wilson H; Mahe, Marc A; Fortin, Andre; Nieder, Carsten; Meyers, Christina A; Smith, Jennifer A; Miller, Richard A; Renschler, Markus F

sustainable development goals

authors

publication date

  • March 15, 2009

webpage

published in

keywords

  • Brain metastases
  • EXPRESSION
  • Life Sciences & Biomedicine
  • METABOLISM
  • Motexafin gadolinium
  • Neurocognitive function
  • Neurologic progression
  • Non-small-cell lung cancer
  • Oncology
  • RADIATION
  • RANDOMIZED-TRIAL
  • Radiology, Nuclear Medicine & Medical Imaging
  • SURVIVAL
  • Science & Technology
  • TEXAPHYRIN
  • Whole brain radiotherapy

Digital Object Identifier (DOI)

publisher

  • ELSEVIER SCIENCE INC

start page

  • 1069

end page

  • 1076

volume

  • 73

issue

  • 4